Viewing Study NCT00462202


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2025-12-26 @ 2:35 AM
Study NCT ID: NCT00462202
Status: TERMINATED
Last Update Posted: 2017-03-03
First Post: 2007-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
Sponsor: Keryx Biopharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module